Next Article in Journal
Biosynthetic Gas Vesicles from Halobacteria NRC-1: A Potential Ultrasound Contrast Agent for Tumor Imaging
Previous Article in Journal
siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells
Previous Article in Special Issue
Citric Acid: A Multifunctional Pharmaceutical Excipient
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Oxidized Chitosan-Tobramycin (OCS-TOB) Submicro-Fibers for Biomedical Applications

1
Institute for Frontier Materials, Deakin University, Geelong, VIC 3216, Australia
2
Hubei Digital Textile Equipment Key Laboratory, Wuhan Textile University, Wuhan 430073, China
3
Agricultural Product Processing Research Institute, Chinese Academy of Tropical Agricultural Sciences, Zhanjiang 524001, China
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2022, 14(6), 1197; https://doi.org/10.3390/pharmaceutics14061197
Submission received: 5 May 2022 / Revised: 29 May 2022 / Accepted: 1 June 2022 / Published: 3 June 2022

Abstract

:
Chitosan (CS) is a biodegradable, biocompatible, and non-toxic natural amino-poly-saccharide with antibacterial ability, owing to its positively charged amino groups. However, the low charge density leads to poor antibacterial efficiency which cannot meet the biomedical application requirements. In this study, Tobramycin (TOB) was grafted onto the backbone of oxidized chitosan (OCS) to synthesize oxidized chitosan-tobramycin (OCS-TOB). FTIR, 1H NMR and elemental analysis results demonstrated that OCS-TOB was successfully synthesized. OCS-TOB/PEO composite fibrous materials were produced by a self-made centrifugal spinning machine. In vitro experiments showed that cells proliferated on the submicro-fibrous OCS-TOB/PEO of appropriate concentration, and the antibacterial ability of OCS-TOB was much improved, compared with pristine CS. The results demonstrated that OCS-TOB/PEO nanofibrous materials could potentially be used for biomedical applications.

1. Introduction

As a natural amino-poly-saccharide, chitosan (CS) has been widely used for biomedical applications because it is biodegradable, biocompatible, non-toxic and antibacterial [1]. Its antibacterial ability is mainly attributed to its amino groups located on the backbone of CS. This unique ability is different from other nature biomaterials, such as gelatin [2] and zein [3]. Those positively charged amino groups can directly attract the negatively charged bacterial cell membrane [4], which is different from the antibiotics via a target-specific effect [5]. However, the low charge density of CS limits its antibacterial efficiency [6]. Additionally, natural CS can only be dissolved into an aqueous acidic solutions, which hinders its application [7]. In order to improve the antibacterial ability and the water solubility, therefore, it is important to modify CS backbone by grafting abundant amino and hydroxyl groups.
Tobramycin (TOB) is a water-soluble and broad-spectrum aminoglycoside antibiotic with abundant amino groups and has been widely utilized for anti-infection [8]. Recently, TOB has been loaded in poly(acrylic acid)-grafted-chitosan bio-film to improve the antibacterial activity [9], and loaded in chitosan-coated poly(lactic-co-glycolic acid) (PLGA) nanoparticles to study its effectiveness against chronic P. aeruginosa infection for pulmonary treatment [10]. Loading low or non-cytotoxicity drugs onto natural bio-polymers with non-toxic solvent to minimize the side effect of artificial biomaterials is still a challenge.
Compared with hydrogels [11], nanoparticles [12] and nanofilms [13], nano and submicro-fibrous biomaterials have huge potential biomedical applications, owing to their structural features and functions that are similar to the native extracellular matrix (ECM) [14] and conductive to cell adsorption and proliferation [15]. Centrifugal spinning is used to produce uniform nanofibers with significantly high production rate (1 mL per minute for lab scale) and low energy consumption compared with electrospinning [16,17] and blow spinning [18]. Moreover, the uniform nanofibers produced via centrifugal spinning are 3D structures and are highly porous, which will be helpful to improve cell adsorption and proliferation in biomedical applications. The process of centrifugal spinning can be divided into three stages: jet-initiating, jet-extension and solvent evaporation [19,20]. In brief, the liquid polymer material (solution or melt) is ejected through the designed nozzles by centrifugal force, then the jet liquid is extended before the solidified nano-fibers are formed and deposited on the collector after the solvent evaporation or melt cooling [21]. Owing to the large-scale production with low cost, centrifugal spinning has a huge potential for commercial bio-medical applications [14,22,23].
In the current study, we grafted TOB onto oxidized chitosan (OCS). Owing to the abundant amino and hydroxyl groups on TOB, the antibacterial property and water solubility of CS/TOB composites was improved. Furthermore, the toxic side effects and aminoglycoside resistance of TOB could be alleviated or eliminated, since the TOB molecules are fixed on a CS backbone and their motion can be restricted by the macromolecular chain of CS. Meanwhile, polyethylene oxide (PEO), a biodegradable and biocompatible synthetic polymer [24], was mixed with synthesized OCS-TOB solution to improve the spinnability of OCS-TOB. Therefore, uniform OCS-TOB/PEO submicro-fibers were fabricated via a centrifugal spinning method. Chemical structure, thermal property, wettability, mechanical property, antibacterial activities and cytotoxicity of the produced OCS-TOB/PEO submicro-fibers were also discussed and analyzed systematically in this study. It is anticipated that the novel chitosan composite sub-microfibers with strong antibacterial ability and water solubility have great potential for biomedical application.

2. Materials and Methods

2.1. Materials

Chitosan (86.5% degree of deacetylation, viscosity 100~200 mPa s−1) was purchased from Qingdao BZ Oligo biotech CO (Qingdao, China). Tobramycin (TOB) was purchased from Shanghai McLean Biochemical Technology Co., Ltd. (Shanghai, China). Polyethylene oxide (PEO, average Mw~1,000,000) was purchased from Aladdin Reagents Co., Ltd. (Shanghai, China). Escherichia coli (E. coli, CMCC(B) 44103) and Staphylococcus aureus (S. aureus, ATCC 25923) were obtained from the China Center of Industrial Culture Collection, Beijing, China. All other reagents were analytical grade and used without further purification.

2.2. Synthesis of OCS-TOB

The purified CS was oxidized using procedures reported previously with slight changes [25]. CS powders were added into 1% of glacial acetic acid aqueous solution and stirred until they were entirely dissolved. The obtained solution was filtered by microporous membrane filter (Nylon, pore size 1 µm) to remove the tiny undissolved particles and achieve the CS solution. The CS solution was neutralized with diluted NaOH solution (1 × 10−3 mol/L) and the purified CS was obtained after drying.
3 g purified CS was dissolved in 200 mL of 1% of glacial acetic acid aqueous solution and stirred 12 h to achieve a homogeneous CS solution. Then, 100 mL sodium periodate (1.99 g) aqueous solution was added into the purified CS solution. The solution was allowed to react in darkness at 40 °C for 1 h. Ethylene glycol (1.74 g) was added to terminate the reaction. The reacted solution was dialyzed in a dialysis bag (8–14 kDa) for three days and lyophilized. OCS was then obtained. In order to get rid of the insoluble gel OCS, which was attributed to the Schiff base reaction, the obtained OCS was dissolved in 1% acetic acid and filtered by a nylon micro-pore membrane.
The purified OCS powders were introduced into 10 w/v% TOB aqueous solution, and 2 drops of triethylamine (TEA) was added into the mixture solution and reacted on a shaker at 100 rpm for 6 h (pH = 6–7, 55 °C). After reaction, sodium cyanoborohydride solution was introduced for 1 h at 30 °C. Synthesized OCS-TOB was then washed with anhydrous ethanol two to three times so as to remove residual TOB, TEA and NaCNBH3. The reacted solution was dialyzed in a dialysis bag (8–14 kDa) for three days and lyophilized. Finally, purified OCS-TOB was obtained.

2.3. Fabrication of OCS-TOB/PEO Submicro-Fibers

Predetermined PEO powder was added into DI water to prepare the 7 w/v% PEO solution. 0.7 g OCS-TOB powders were introduced into 20 mL, 30 mL and 40 mL 7 w/v% PEO solutions, respectively. Therefore, the mass ratio of OCS-TOB to PEO in three solutions was 1:2, 1:3 and 1:4. OCS-TOB/PEO solutions at these three different ratios were stirred for 8 h at 25 °C so as to obtain homogeneous OCS-TOB/PEO solutions.
In the process of OCS-TOB/PEO submicro-fibers fabrication, the following key operational conditions in centrifugal spinning were used: rotational speed: 4500 rpm; inner diameter of nozzle: 0.31 mm; nozzle length: 5 mm; turning radius of nozzle: 10 cm and collection distance: 30 cm. All experiments were operated at room temperature with 46%RH.

2.4. Characterizations

Fourier transform infrared spectroscopy with a universal attenuated total reflection (FTIR-ATR, Vertex-70, Bruker, Karlsruhe, Germany) was used to determine chemical characteristics. All submicro-fiber scaffolds were tested at wavelengths in the range of 4000–400/cm and at a resolution of 1/cm with 64 scans. The 1H nuclear magnetic resonance spectrum (1H NMR) was tested by a Fourier Nuclear Magnetic Resonance Instrument (400M, Bruker, Karlsruhe, Germany) using a mixed solvent of CD3COOD and D2O at room temperature. Element contents were tested by an elemental analyzer (Flash EA 1112, Thermo Fisher Scientific, Waltham, MA, USA) and the previous calculation method was followed [26].
The morphology of submicro-fibers was observed by scanning electron microscopy (SEM, JSM-7800F, JEOL, Tokyo, Japan). Before testing, the obtained submicro-fibers were coated with Au by sputter coater (JFC-1600, JEOL, Tokyo, Japan), and the diameters of the fibers were measured by ImageJ software. For each fiber specimen, three different SEM images were used and 100 counts of fibers were measured to calculate fiber diameters.
AR-2000ex rheometer (TA Instruments, New Castle, DE, USA) was used to test the viscosities of polymer solutions at room temperature. A parallel plate (40 mm diameter) was applied to test each sample with a gap in 500 μm. The viscosity of polymer solutions was tested with an increasing shear rate from 0.1/s to 1000/s. The thermal properties of fibers were tested by Thermogravimetric (TGA, 209F1, Netzsch, Selb, Germany). Approximately 5 mg fibers were used for each type of sample. For each testing, the temperature increased from 30 °C to 800 °C with a heating rate of 10 °C/min, and this decreased from 800 °C to 30 °C with a cooling rate of 20 °C/min. A contact angle goniometer equipped with a CCD camera (Kruss, DSA 100, WCA, Frankfurt, Germany) was used to test the contact angles of DI water on the surface of the produced submicro-fiber mats. For each contact angle test, 10 μL DI water droplet was gently placed on the surface of the sample via a micro-plate syringe. The mechanical test of submicro-fibers was performed via an Instron 5943 with a 50 N load cell. The submicro-fibers were twisted into a yarn with 0.5 mm diameter and cut into 1 cm long, and the extension rate was set at 2 mm/min. Young’s modulus and failure work were calculated from the recorded stress-strain curve. At least three tests for each type of sample were undertaken.

2.5. Cell Viability Assay

The cell viability assessment of OCS-TOB/PEO submicro-fibers was evaluated via mouse fibroblast cells (L929) using an MTT assay. Briefly, the L929 cells were seeded into 96-well plates with a density of 5 × 103 cells per well and cultured at 37 °C for 24 h in an incubator with a moist air condition of 5% CO2. The cultured cells were washed by PBS twice and replaced the original medium with 100 μL sample solution at various concentrations (50–6400 μg/mL). After 24 h incubation, 20 μL MTT (0.5 mg/mL) was added into each well for another 4 h incubation. After removing the mixed medium, 150 μL DMSO was added to dissolve the insoluble formazan crystals. Finally, the dissolved solution was shaken for 10 min and measured by an enzyme-linked immune analyzer at 570 nm. The cells of the control group did not receive further treatment and all experiments were operated six times. The cell viability was expressed as a percentage according to the following formula:
C e l l   v i a b i l i t y   % = O D s a m p l e O D b l a n k O D c o n t r o l O D b l a n k × 100 %
where, O D s a m p l e , O D c o n t r o l and O D b l a n k are the optical density of sample, control and blank, respectively.

2.6. Antibacterial Assay

An inhibition zone experiment was utilized to assess the antibacterial properties of OCS-TOB via the AGAR disc diffusion method [27]. The antibacterial abilities of OCS-TOB powders were compared with those of CS powders and traditional water-soluble chitosan (WSCS) powders. Furthermore, different ratios of OCS-TOB/PEO submicro-fibers were also used to test their antibacterial abilities with a control. E. coli and S. aureus were selected to assess the antibacterial properties of prepared materials.
All prepared samples were sterilized by UV for 30 min before experiments. Sterile water and glacial acetic acid were used to prepare 0.5% dilute acetic acid, and then chitosan samples were dissolved into the prepared 0.5% dilute acetic acid to prepare 1 wt.% drug solution. A bacterial solution was incubated with nutrient broth in a shaker at 120 rpm at 37 °C for 18 h. The bacterial solution was diluted 300–400 times. One mL of diluted bacterial solution was dropped into AGAR at 50 °C and then was allowed to cool and coagulate. A 10 μL drug solution was dropped into a 5 mm diameter disc and left for 30 min. The inhibition zone was photographed, and the diameter of the inhibition zone was measured after 24 h culture at 37 °C.

2.7. Statistical Analysis

The statistical analysis of all data was calculated as mean + standard deviation (SD) and performed using one-way ANOVA. A probability value p < 0.05 was considered statistically significant.

3. Results and Discussion

3.1. OCS-TOB Syntheses and Characterizations

3.1.1. Mechanism of Synthesis

The synthesis mechanism of OCS-TOB is shown in Figure 1a. First of all, CS is oxidized by NaIO4, resulting in the cleavage of C2-C3 bonds and the formation of aldehyde groups. Secondly, TOB is grafted onto the OCS by the Schiff base reaction. Finally, the -C=N- bond between TOB and OCS is replaced by -C-NH-, and TOB was grafted onto the backbone of OCS after the reductive amination by NaCNBH3.

3.1.2. FTIR Analysis

FTIR spectra for synthesized OCS-TOB are shown in Figure 1b. For CS, the peak at 3423 cm−1 corresponds to the O-H stretching vibration, while the peaks at 2918 cm−1 and 2854 cm−1 correspond to the C-H stretching vibration; the peak at 1641 cm−1 corresponds to the O-H and C=O stretching vibrations; 1550 cm−1 corresponds to the N-H bending vibration; 1424 cm−1 and 1384 cm−1 corresponds to the C-H bending vibration; and 1159 cm−1 and 1100 cm−1 correspond to the C-O-C stretching vibration. In the OCS curve, 1744 cm−1 corresponds to the C=O stretching vibration in aldehyde carbonyl or carboxylic acid carbonyl, while the C-O-C stretching vibration is transferred to 1155 cm−1 and 1076 cm−1, and the other peaks are consistent with CS. This indicates that CS is oxidized. In the OCS-TOB curve, the peaks at 1571 cm−1 and 1550 cm−1 correspond to the N-H bending vibration in TOB and OCS, respectively; the peaks at 1155 cm−1 and 1077 cm−1 correspond to C-O-C stretching vibration. The results demonstrate that CS and TOB share the functional groups (-NH and C-O-C), and the C-O-C stretching vibration in TOB is covered by that in CS, while two N-H bending vibrations indicate that a very small amount of TOB is grafted onto OCS.

3.1.3. NMR Analysis

The 1H NMR spectra of CS, OCS and OCS-TOB are shown in Figure 1c. Signal peaks of CS are consistent with a previous study [25]. The peaks at 2.98 ppm and 4.67 ppm are H2 and H2′, respectively; the multiple peaks between the range of 3.50–3.70 ppm correspond to methylene protons H3, H4, H5 and H6. After oxidation, the periodate ion cleaved the C-C bond, the intensity of peak at 2.98 ppm decreases, and a new peak appears at 8.07 ppm in OCS. It indicates that H on C2 decrease and the aldehyde group is generated. In the OCS-TOB spectrum, a new peak at 8.14 ppm appears owing to the protonated hydrogen of C on C=N during Schiff’s base reaction between the aldehyde group of OCS and the terminal amino group of TOB.

3.1.4. Elemental Analysis

The mass percentage of chemical elements can demonstrate their quantitative relationship in a particular compound [25]. The elemental analyses of CS, OCS and OCS-TOB are presented in Table 1. The ratio of C/N in OCS is higher than that in CS, which is attributed to the emission of ammonia during the oxidation of CS [28]. The N percentage in OCS-TOB is lower than that of OCS, owing to the grafting of TOB onto OCS. According to the C/N changes, the grafting rate is approximately 18.3%.

3.2. Characterization of OCS-TOB/PEO Submicro-Fibers

3.2.1. Submicro-Fiber Morphology

The morphology of nano-fibers has a significant influence on cell proliferation in biomedical applications [15]. In the centrifugal spinning method, the nano-fiber morphology was determined by the rheological properties of the polymer solution and operational conditions [29,30], including viscosity, rotational speed, nozzle diameter and nozzle length [17].
The centrifugal spinning machine was self-designed and assembled via the “Digital Twins” conception, as shown in Figure 2a,b. It means that a simulated machine is made in a virtual world before manufacturing a real one, then the mechanical structure of the machine can be optimized and improved during simulation so as to save time and cost. Figure 2c shows that the viscosity of the 1:2 OCS-TOB/PEO solution starts from around 59 Pas, peaking to about 63 Pas at 0.2/s, and then decreasing with the increasing shear rate. When the shear rate is higher than 100/s, the relationship between solution viscosity and shear rate becomes almost linear. All OCS-TOB/PEO solutions have similar rheological behaviors. The viscosities for the three OCS-TOB/PEO solutions of different ratios are very similar, although the 1:2 OCS-TOB/PEO solution has a slightly higher viscosity. This indicates that the rheological behaviors of the polymer solution are not significantly influenced by changing the content of OCS-TOB. Therefore, it could be assumed that the sub micro-fibers produced from these three OCS-TOB/PEO solutions of different ratios could have similar morphologies if other operational conditions are remained the same.
The SEM images and fiber diameter distributions of OCS-TOB/PEO sub micro-fibers of the three different ratios are shown in Figure 2d–f. The average diameter of sub micro-fibers increases slightly from 668 nm to 701 nm when the ratio of OCS-TOB/PEO decreases from 1:2 to 1:3. However, the average diameter slightly decreases to 624 nm at 1:4 OCS-TOB/PEO. In addition, the standard deviation of the three samples remains at about 200 nm, regardless of the changing ratio of OCS-TOB/PEO.

3.2.2. Thermal Properties

The thermal properties of the produced OCS-TOB/PEO sub micro-fibers were characterized by thermogravimetric analyses (TGA), and are shown in Figure 3a. The weight of these three samples hardly decreases before 250 °C, which means that the produced sub micro-fibers are highly desiccative [17]. When the temperature reaches 250 °C, the composite sub micro-fibers start degrading. Between 250–350 °C, all samples have an obvious mass loss, and the mass loss increases with the increasing OCS-TOB content. The sample with a higher content of OCS-TOB leads to a bigger mass loss in this range. This might be because the nitrides (such as amino groups) are degraded at this stage. At the range of 350–410 °C, the mass of these samples has declined dramatically, and all of them have less than 20 p of the total mass remaining after 410 °C. The sample with a higher content of PEO leads to a bigger mass loss at this stage. This might attribute to carbides (including aldehyde groups) that are carbonized. After that, the samples are stable and hardly lose any mass, and the sample with higher percentage of OCS-TOB has a higher residual mass.

3.2.3. Mechanical Properties

The mechanical properties of OCS-TOB/PEOs with different ratios are shown in Figure 3b. For 1:2 OCS-TOB/PEO, the tensile strain is slightly higher than 100% and the tensile stress is 4.2 MPa; for 1:3 OCS-TOB/PEO, the tensile strain and tensile stress increase to around 150% and 6.2 MPa, respectively; and for 1:4 OCS-TOB/PEO, the tensile strain and tensile stress further increase to approximately 180% and 8.2 MPa, respectively. The result indicates that when the content of OCS-TOB decreases from 1:2 to 1:4, both of the tensile strain and tensile stress of OCS-TOB composite sub micro-fibers are significantly increased. Therefore, the mechanical strength of OCS-TOB/PEO composite sub micro-fibers increases with increasing the percentage of PEO. All three OCS-TOB/PEO sub micro-fibers are strong enough for cell migration and proliferation in tissue engineering applications as the tensile stress of ECM is at the recommended range of 0.8–18 MPa [31,32].
Mechanical properties of sub micro-fibers are strongly influenced by many factors, including chemical structure of polymers and physical properties of fibers (structure, morphology and diameter). Therefore, the mechanical properties might attribute to the strong intramolecular or intermolecular hydrogen bonds in PEO as reflected by the semi-crystalline phase of PEO [33,34]. Hydrogen bonds also exist in OCS-TOB but are formed between aldehyde group of oxide CS and terminal amino groups [25], which has a relatively lower strength than the hydrogen bonds in PEO. The molecular weight also only has limited effects but cannot be excluded (the molecular weight of PEO is larger than OCS-TOB) [33].

3.2.4. Wettability Studies

Figure 3c–e show the hydrophilicity of the produced OCS-TOB/PEO composite sub micro-fiber mats. The water contact angle of 1:2 OCS-TOB/PEO sub micro-fibers is 83.5°. As the percentage of PEO in OCS-TOB/PEO composite sub micro-fiber scaffold increases, the contact angle orderly decreases to 64.1° for 1:3 OCS-TOB/PEO and 43.3° for 1:4 OCS-TOB/PEO sub micro-fiber mats, respectively. As previously reported, the contact angle of pure PEO cast film is 21° [35]. It demonstrates that the wettability of OCS-TOB/PEO sub micro-fiber mat increases as the content of PEO increases, which might be attributed to the water-soluble ability of PEO which is better than OCS-TOB.

3.3. Cell Viability Assay

The viability of L929 on OCS-TOB/PEO sub micro-fibers with different concentrations of medium extracts is shown in Figure 4a. It is observed that the cell viability of 1:4 OCS-TOB/PEO is higher than that of 1:2 OCS-TOB/PEO at the same concentration. Therefore, a higher content of OCS-TOB inhibits cell proliferation, owing to its cytotoxicity. Additionally, the samples at 50 μg/mL and 100 μg/mL showed very similar and high proliferation ability. Then, the cell viability continuously decreases as the concentration increases from 100 μg/mL to 6400 μg/mL. It indicates that a low concentration (50 μg/mL and 100 μg/mL) of OCS-TOB/PEO contributes to cell proliferation, while a high concentration (>100 μg/mL) shows toxicity and significantly decreases the cell viability. The results demonstrate that an appropriate (such as 50–100 μg/mL) concentration of OCS-TOB/PEO can be potentially used for cell proliferation, and lower concentration of drugs usually has a lower drug-induced risk.

3.4. Antibacterial Assay

Figure 4b,c and Table 2 show the inhibition effect of chitosan and its derivatives on E. coli and S. aureus. OCS-TOB has the largest inhibition zones (over 18 mm) in E. coli and S. aureus, natural CS has limited antibacterial effects on both E. coli and S. aureus, and traditional water-soluble chitosan (WSCS) hardly inhibits the growth of those two kinds of bacteria. The results demonstrate that WSCS hardly has antibacterial ability, while synthesized water-soluble OCS-TOB significantly improves the antibacterial properties of natural CS. This might be because the positive charge density of OCS-TOB is much higher than the others and therefore, there are more electrostatic attractions between positively charged OCS-TOB and negatively charged bacterial cell membranes, owing to grafted TOB [36].
OCS-TOB is a water-soluble chitosan derivative. OCS-TOB/PEO composite sub micro-fibers of different ratios can inhibit bacterial growth, as shown in Figure 4d,e and Table 2. OCS-TOB/PEO composite sub micro-fibers have a similar effect on inhibitions of both E. coli and S. aureus, and the size of inhibition zone increases as the OCS-TOB content increasing. However, when the ratio of OCS-TOB/PEO increased to 1:2, the inhibition zone size is still 18.21 mm, which is almost the same as that for 1:3 OCS-TOB/PEO. 1:2 OCS-TOB/PEO does not show larger inhibition zone size than 1:3 OCS-TOB/PEO, which might be because the drug diffusion ability limited inhibition effect. It indicates that 1:3 OCS-TOB/PEO could maximize the antibacterial ability, when considering the cytotoxicity of OCS-TOB.

4. Conclusions

In this study, TOB was grafted onto the oxidized chitosan, aiming at improving the antibacterial property and water-solubility of chitosan. The water-solubility of synthesized OCS-TOB was significantly improved to 7 w/v%, which indicated that TOB was successfully grafted onto the oxidized chitosan. The uniform OCS-TOB/PEO composite sub micro-fiber mats with controlled hydrophilicity properties can be produced by controlling the parameters. Produced OCS-TOB/PEO sub micro-fibers were characterized by FTIR, TGA, and mechanical test. They demonstrated that OCS-TOB/PEO sub micro-fibers via centrifugal spinning method have stable chemical and physical properties. Inhibition zone test demonstrated that the antibacterial properties of OCS-TOB significantly improved (around 19 mm), comparing with natural chitosan (around 9 mm) and WSCS (almost 0 mm). Higher contents of OCS-TOB in OCS-TOB/PEO composite sub micro-fibers lead to better antibacterial effect, however, when the ratio of OCS-TOB/PEO is over 1:3, the antibacterial efficiency of OCS-TOB/PEO composite sub micro-fibers hardly increased. Low concentration (50 μg/mL and 100 μg/mL) of OCS-TOB/PEO sub micro-fibers are conductive to cell proliferation, comparing with high concentration (>100 μg/mL). Overall consideration of both cytotoxicity and antibacterial ability, 1:3 OCS-TOB/PEO composite sub micro-fibrous had shown the potential for medical applications.

Author Contributions

Conceptualization, L.K. and Z.L.; methodology, Z.L. and F.S.; software, Y.D. and Z.L.; validation, Y.L., Y.D. and Z.L.; formal analysis, Z.L. and C.L.; investigation, Z.L. and C.L.; resources, S.M. and L.K.; data curation, Z.L.; writing—original draft preparation, Z.L.; writing—review and editing, L.K.; visualization, Z.L.; supervision, S.M. and L.K.; project administration, S.M. and L.K.; funding acquisition, S.M., Y.L. and L.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Science and Technology Program of Hubei Province (grant numbers 2019AEE011 and 2018AAA036); the National Natural Science Foundation of China (grant number 51175385); and the Central Public-Interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences (grant numbers 1630122017010).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

This work was performed in part at the Institute for Frontier Materials at Deakin University using in-kind equipment/resources from the Victorian Node of the Australian National Fabrication Facility (ANFF).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Li, C.; Huang, Y.; Li, R.; Wang, Y.; Xiang, X.; Zhang, C.; Wang, D.; Zhou, Y.; Liu, X.; Xu, W. Fabrication and properties of carboxymethyl chitosan/polyethylene oxide composite nonwoven mats by centrifugal spinning. Carbohydr. Polym. 2020, 251, 117037. [Google Scholar] [CrossRef] [PubMed]
  2. Unalan, I.; Endlein, S.J.; Slavik, B.; Buettner, A.; Goldmann, W.H.; Detsch, R.; Boccaccini, A.R. Evaluation of Electrospun Poly(epsilon-Caprolactone)/Gelatin Nanofiber Mats Containing Clove Essential Oil for Antibacterial Wound Dressing. Pharmaceutics 2019, 11, 570. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Moradkhannejhad, L.; Abdouss, M.; Nikfarjam, N.; Mazinani, S.; Heydari, V. Electrospinning of zein/propolis nanofibers; antimicrobial properties and morphology investigation. J. Mater. Sci. Mater. Med. 2018, 29, 165. [Google Scholar] [CrossRef] [PubMed]
  4. Chabala, L.F.G.; Cuartas, C.E.E.; López, M.E.L. Release Behavior and Antibacterial Activity of Chitosan/Alginate Blends with Aloe vera and Silver Nanoparticles. Mar. Drugs 2017, 15, 328. [Google Scholar] [CrossRef] [Green Version]
  5. Cazón, P.; Velazquez, G.; Ramírez, J.A.; Vázquez, M. Polysaccharide-based films and coatings for food packaging: A review. Food Hydrocoll. 2017, 68, 136–148. [Google Scholar] [CrossRef]
  6. Biao, L.; Tan, S.; Wang, Y.; Guo, X.; Fu, Y.; Xu, F.; Zu, Y.; Liu, Z. Synthesis, characterization and antibacterial study on the chitosan-functionalized Ag nanoparticles. Mater. Sci. Eng. C 2017, 76, 73–80. [Google Scholar] [CrossRef]
  7. Zhang, E.; Xing, R.; Liu, S.; Qin, Y.; Li, K.; Li, P. Advances in chitosan-based nanoparticles for oncotherapy. Carbohydr. Polym. 2019, 222, 115004. [Google Scholar] [CrossRef]
  8. Hill, M.; Twigg, M.; Sheridan, E.A.; Hardy, J.G.; Elborn, J.S.; Taggart, C.C.; Scott, C.J.; Migaud, M.E. Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary Applications. Pharmaceutics 2019, 11, 379. [Google Scholar] [CrossRef] [Green Version]
  9. Lee, H.S.; Dastgheyb, S.S.; Hickok, N.J.; Eckmann, D.M.; Composto, R.J. Targeted Release of Tobramycin from a pH-Responsive Grafted Bilayer Challenged with S. aureus. Biomacromolecules 2015, 16, 650–659. [Google Scholar] [CrossRef] [Green Version]
  10. Al-Nemrawi, N.K.; Alshraiedeh, N.H.; Zayed, A.L.; Altaani, B.M. Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis. Pharmaceuticals 2018, 11, 28. [Google Scholar] [CrossRef] [Green Version]
  11. Wang, J.; Chen, X.Y.; Zhao, Y.; Yang, Y.; Wang, W.; Wu, C.; Yang, B.; Zhang, Z.; Zhang, L.; Liu, Y. pH-Switchable Antimicrobial Nanofiber Networks of Hydrogel Eradicate Biofilm and Rescue Stalled Healing in Chronic Wounds. ACS Nano 2019, 13, 11686–11697. [Google Scholar] [CrossRef]
  12. Kalantari, K.; Mostafavi, E.; Afifi, A.M.; Izadiyan, Z.; Jahangirian, H.; Rafiee-Moghaddam, R.; Webster, T.J. Wound dressings functionalized with silver nanoparticles: Promises and pitfalls. Nanoscale 2019, 12, 2268–2291. [Google Scholar] [CrossRef]
  13. Alavi, M.; Nokhodchi, A. An overview on antimicrobial and wound healing properties of ZnO nanobiofilms, hydrogels, and bionanocomposites based on cellulose, chitosan, and alginate polymers. Carbohydr. Polym. 2019, 227, 115349. [Google Scholar] [CrossRef]
  14. Li, Z.; Mei, S.; Dong, Y.; She, F.; Li, Y.; Li, P.; Kong, L. Functional Nanofibrous Biomaterials of Tailored Structures for Drug Delivery—A Critical Review. Pharmaceutics 2020, 12, 522. [Google Scholar] [CrossRef]
  15. Fan, L.; Li, J.-L.; Cai, Z.; Wang, X.-G. Creating Biomimetic Anisotropic Architectures with Co-Aligned Nanofibers and Macrochannels by Manipulating Ice Crystallization. ACS Nano 2018, 12, 5780–5790. [Google Scholar] [CrossRef]
  16. Nava, R.; Cremar, L.; Agubra, V.; Sánchez, J.; Alcoutlabi, M.; Lozano, K. Centrifugal Spinning: An Alternative for Large Scale Production of Silicon–Carbon Composite Nanofibers for Lithium Ion Battery Anodes. ACS Appl. Mater. Interfaces 2016, 8, 29365–29372. [Google Scholar]
  17. Li, Z.; Mei, S.; Dong, Y.; She, F.; Kong, L. High Efficiency Fabrication of Chitosan Composite Nanofibers with Uniform Morphology via Centrifugal Spinning. Polymers 2019, 11, 1550. [Google Scholar] [CrossRef] [Green Version]
  18. Medeiros, E.S.; Glenn, G.M.; Klamczynski, A.P.; Orts, W.J.; Mattoso, L.H.C. Solution blow spinning: A new method to produce micro- and nanofibers from polymer solutions. J. Appl. Polym. Sci. 2009, 113, 2322–2330. [Google Scholar] [CrossRef]
  19. Badrossamay, M.R.; McIlwee, H.A.; Goss, J.A.; Parker, K.K. Nanofiber Assembly by Rotary Jet-Spinning. Nano Lett. 2010, 10, 2257–2261. [Google Scholar] [CrossRef] [Green Version]
  20. Li, Z.; Mei, S.; Dong, Y.; She, F.; Li, P.; Li, Y.; Kong, L. Multi-Functional Core-Shell Nanofibers for Wound Healing. Nanomaterials 2021, 11, 1546. [Google Scholar] [CrossRef]
  21. Golecki, H.M.; Yuan, H.; Glavin, C.; Potter, B.; Badrossamay, M.R.; Goss, J.A.; Phillips, M.D.; Parker, K.K. Effect of Solvent Evaporation on Fiber Morphology in Rotary Jet Spinning. Langmuir 2014, 30, 13369–13374. [Google Scholar] [CrossRef] [Green Version]
  22. Badrossamay, M.R.; Balachandran, K.; Capulli, A.K.; Golecki, H.M.; Agarwal, A.; Goss, J.A.; Kim, H.; Shin, K.; Parker, K.K. Engineering hybrid polymer-protein super-aligned nanofibers via rotary jet spinning. Biomaterials 2014, 35, 3188–3197. [Google Scholar] [CrossRef] [Green Version]
  23. Mamidi, N.; Romo, I.L.; Gutiérrez, H.M.L.; Barrera, E.V.; Elías-Zúñiga, A. Development of forcespun fiber-aligned scaffolds from gelatin-zein composites for potential use in tissue engineering and drug release. MRS Commun. 2018, 8, 885–892. [Google Scholar] [CrossRef]
  24. Al-Kattan, A.; Nirwan, V.P.; Munnier, E.; Chourpa, I.; Fahmi, A.; Kabashin, A.V. Toward multifunctional hybrid platforms for tissue engineering based on chitosan(PEO) nanofibers functionalized by bare laser-synthesized Au and Si nanoparticles. RSC Adv. 2017, 7, 31759–31766. [Google Scholar] [CrossRef] [Green Version]
  25. Yan, T.; Li, C.; Ouyang, Q.; Zhang, D.; Zhong, Q.; Li, P.; Li, S.; Yang, Z.; Wang, T.; Zhao, Q. Synthesis of gentamicin-grafted-chitosan with improved solubility and antibacterial activity. React. Funct. Polym. 2019, 137, 38–45. [Google Scholar] [CrossRef]
  26. Liang, F.; Sun, C.; Li, S.; Hou, T.; Li, C. Therapeutic effect and immune mechanism of chitosan-gentamicin conjugate on Pacific white shrimp (Litopenaeus vannamei) infected with Vibrio parahaemolyticus. Carbohydr. Polym. 2021, 269, 118334. [Google Scholar] [CrossRef]
  27. Liang, L.; Hou, T.; Ouyang, Q.; Xie, L.; Zhong, S.; Li, P.; Li, S.; Li, C. Antimicrobial sodium alginate dressing immobilized with polydopamine-silver composite nanospheres. Compos. Part B Eng. 2020, 188, 107877. [Google Scholar] [CrossRef]
  28. Keshk, S.M.; Ramadan, A.; Al-Sehemi, A.G.; Irfan, A.; Bondock, S. An unexpected reactivity during periodate oxidation of chitosan and the affinity of its 2, 3-di-aldehyde toward sulfa drugs. Carbohydr. Polym. 2017, 175, 565–574. [Google Scholar] [CrossRef]
  29. Zhang, X.; Lu, Y. Centrifugal Spinning: An Alternative Approach to Fabricate Nanofibers at High Speed and Low Cost. Polym. Rev. 2014, 54, 677–701. [Google Scholar] [CrossRef]
  30. Kenry; Lim, C.T. Nanofiber technology: Current status and emerging developments. Prog. Polym. Sci. 2017, 70, 1–17. [Google Scholar] [CrossRef]
  31. Singh, R.; Ahmed, F.; Polley, P.; Giri, J. Fabrication and Characterization of Core–Shell Nanofibers Using a Next-Generation Airbrush for Biomedical Applications. ACS Appl. Mater. Interfaces 2018, 10, 41924–41934. [Google Scholar] [CrossRef] [PubMed]
  32. Cheng, J.; Li, H.; Cao, Z.; Wu, D.; Liu, C.; Pu, H. Nanolayer coextrusion: An efficient and environmentally friendly micro/nanofiber fabrication technique. Mater. Sci. Eng. C 2018, 95, 292–301. [Google Scholar] [CrossRef] [PubMed]
  33. Chen, S.; Cui, S.; Hu, J.; Zhou, Y.; Liu, Y. Pectinate nanofiber mat with high absorbency and antibacterial activity: A potential superior wound dressing to alginate and chitosan nanofiber mats. Carbohydr. Polym. 2017, 174, 591–600. [Google Scholar] [CrossRef] [PubMed]
  34. Furlan, R.; Rosado, J.A.M.; Rodriguez, G.G.; Fachini, E.R.; Da Silva, A.N.R.; Da Silva, M.L.P. Formation and Characterization of Oriented Micro- and Nanofibers Containing Poly (ethylene oxide) and Pectin. J. Electrochem. Soc. 2012, 159, K66–K71. [Google Scholar] [CrossRef] [Green Version]
  35. Buddhiranon, S.; Define, L.A.; Alexander, T.S.; Kyu, T. Genistein-Modified Poly(ethylene oxide)/Poly(d,l-lactic acid) Electrospun Mats with Improved Antioxidant and Anti-inflammatory Properties. Biomacromolecules 2013, 14, 1423–1433. [Google Scholar] [CrossRef]
  36. Chen, S.; Li, C.; Hou, T.; Cai, Y.; Liang, L.; Chen, L.; Li, M. Polyhexamethylene guanidine functionalized chitosan nanofiber membrane with superior adsorption and antibacterial performances. React. Funct. Polym. 2019, 145, 104379. [Google Scholar] [CrossRef]
Figure 1. Synthesis of OCS-TOB procedures (a); FTIR curves (b) and 1H NMR spectrum (c) of CS, OCS and OCS-TOB.
Figure 1. Synthesis of OCS-TOB procedures (a); FTIR curves (b) and 1H NMR spectrum (c) of CS, OCS and OCS-TOB.
Pharmaceutics 14 01197 g001
Figure 2. Virtual model and the corresponding optical photo of self-designed centrifugal spinning equipment (a1,a2,b); the viscosities of three different ratios of OCS-TOB/PEO solutions change with shear rate (c); SEM images of OCS-TOB/PEO sub micro-fibers with different ratios of solutions with corresponding fiber diameter distribution, 1:2 OCS-TOB/PEO (d1,d2), 1:3 OCS-TOB/PEO (e1,e2) and 1:4 OCS-TOB/PEO (f1,f2), the scale bar is 5 μm.
Figure 2. Virtual model and the corresponding optical photo of self-designed centrifugal spinning equipment (a1,a2,b); the viscosities of three different ratios of OCS-TOB/PEO solutions change with shear rate (c); SEM images of OCS-TOB/PEO sub micro-fibers with different ratios of solutions with corresponding fiber diameter distribution, 1:2 OCS-TOB/PEO (d1,d2), 1:3 OCS-TOB/PEO (e1,e2) and 1:4 OCS-TOB/PEO (f1,f2), the scale bar is 5 μm.
Pharmaceutics 14 01197 g002
Figure 3. The TGA results of different ratios of OCS-TOB/PEO composite sub micro-fibers (a); mechanical test of the produced OCS-TOB/PEO sub micro-fiber yarn (b); the contact angle test of different ratios of OCS-TOB/PEO sub micro-fiber mats: 1:2 OCS-TOB/PEO (c), 1:3 OCS-TOB/PEO (d) and 1:4 OCS-TOB/PEO (e).
Figure 3. The TGA results of different ratios of OCS-TOB/PEO composite sub micro-fibers (a); mechanical test of the produced OCS-TOB/PEO sub micro-fiber yarn (b); the contact angle test of different ratios of OCS-TOB/PEO sub micro-fiber mats: 1:2 OCS-TOB/PEO (c), 1:3 OCS-TOB/PEO (d) and 1:4 OCS-TOB/PEO (e).
Pharmaceutics 14 01197 g003
Figure 4. Cell viability of 1:2 OCS-TOB/PEO and 1:4 OCS-TOB/PEO in 24 h (a); inhibition effect of CS, WSCS and OCS-TOB against E. coli (b) and S. aureus (c); and inhibition effect of different ratios of OCS-TOB/PEO sub micro-fibers against E. coli (d) and S. aureus (e). Scale bar is 5 mm.
Figure 4. Cell viability of 1:2 OCS-TOB/PEO and 1:4 OCS-TOB/PEO in 24 h (a); inhibition effect of CS, WSCS and OCS-TOB against E. coli (b) and S. aureus (c); and inhibition effect of different ratios of OCS-TOB/PEO sub micro-fibers against E. coli (d) and S. aureus (e). Scale bar is 5 mm.
Pharmaceutics 14 01197 g004
Table 1. Mass percentage of C and N in CS, OCS and OCS-TOB.
Table 1. Mass percentage of C and N in CS, OCS and OCS-TOB.
SamplesC (%)N (%)C/N
CS41.87.595.51
OCS36.236.485.59
OCS-TOB37.905.526.87
Table 2. Average inhibition sizes of CS, WSCS, OCS-TOB and different ratios of OCS-TOB/PEO sub micro-fibers against E. coli and S. aureus.
Table 2. Average inhibition sizes of CS, WSCS, OCS-TOB and different ratios of OCS-TOB/PEO sub micro-fibers against E. coli and S. aureus.
DrugAverage Diameter of Inhibition Zone (mm)Standard Deviation
E. coliS. aureusE. coliS. aureus
CS9.558.910.310.36
WSCS----
OCS-TOB19.4918.660.260.28
1:2 OCS-TOB/PEO18.2118.380.210.25
1:3 OCS-TOB/PEO18.1718.070.220.23
1:4 OCS-TOB/PEO15.5815.670.280.25
Control----
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Li, Z.; Mei, S.; Dong, Y.; She, F.; Li, C.; Li, Y.; Kong, L. Oxidized Chitosan-Tobramycin (OCS-TOB) Submicro-Fibers for Biomedical Applications. Pharmaceutics 2022, 14, 1197. https://doi.org/10.3390/pharmaceutics14061197

AMA Style

Li Z, Mei S, Dong Y, She F, Li C, Li Y, Kong L. Oxidized Chitosan-Tobramycin (OCS-TOB) Submicro-Fibers for Biomedical Applications. Pharmaceutics. 2022; 14(6):1197. https://doi.org/10.3390/pharmaceutics14061197

Chicago/Turabian Style

Li, Zhen, Shunqi Mei, Yajie Dong, Fenghua She, Chengpeng Li, Yongzhen Li, and Lingxue Kong. 2022. "Oxidized Chitosan-Tobramycin (OCS-TOB) Submicro-Fibers for Biomedical Applications" Pharmaceutics 14, no. 6: 1197. https://doi.org/10.3390/pharmaceutics14061197

APA Style

Li, Z., Mei, S., Dong, Y., She, F., Li, C., Li, Y., & Kong, L. (2022). Oxidized Chitosan-Tobramycin (OCS-TOB) Submicro-Fibers for Biomedical Applications. Pharmaceutics, 14(6), 1197. https://doi.org/10.3390/pharmaceutics14061197

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop